LOXO-305 Comes Out Swinging In Battle Of BTK Inhibitors

Lilly's Loxo Presents Positive Phase I/II Data In MCL At ASH

 
• By Alaric DeArment
  
Digital illustration of Cancer cell in colour background
Loxo Oncology at Lilly announces MCL data from Phase I/II study at ASH • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D